glp-1 agonists diabetes GLP1 Receptor Agonists—Effects beyond Obesity and GLP-1 Agonists: A Comprehensive Overview
Description
Mol Metabol

In this experiment, the high protein diet can promote intestinal secretion of GLP-1, improve FGF21 resistance, upregulate LKB1 to activate the AMPK pathway, downregulate the expression of SERBP-1c mRNA and protein in the liver, and ultimately inhibit liver lipid synthesis [50]

But beneath the hype and fear is a simple story: these drugs target a core metabolic signaling pathway that influences cardiovascular health, inflammation, cognition, kidney function, and long-term resilience

How long does treatment last

Large molecule conjugation modification Dulaglutide Dulaglutide is a long-acting GLP-1 receptor agonist that employs Fc-fusion protein technology to achieve prolonged systemic exposure
In pre-clinical models, GLP-1 secretion from enteroendocrine L cells is upregulated via toll-like receptor 4 (TLR4) activation in response to increased lipopolysaccharide (LPS) translocation, secondary to impaired barrier function
